Usage: All products on this site are for In-Vitro Research, Development use only. Products are Not for Human consumption of any kind.
CAS No.: 841205-47-8
Other Names: Ostarine
Brand Name: UNEWLIFE
Grade: Pharm Medicine Grade
MFG: each batch fresh in 2023
Shelf Life: 2 years of proper storage
Appearance: White Powder
Test Reports: MS/COA/HPLC
MOQ: 10 grams raw powder.
Packing: discreet package.
Shipping: by express or post.
Feedback: How do they say? More reviews here
For more questions, check the answers here: FAQ
Ostarine (MK-2866), also known as enobosarm, is a selective androgen receptor modulator (SARM). SARMs like Ostarine stimulate steroid hormone receptors – androgen receptors – mimicking testosterone.
Scientists initially hypothesized that, unlike typical steroids, SARMs would be able to target specific tissues, such as the muscles or bones. In theory, this was supposed to limit their side effects.
Bodybuilders tend to take this unapproved theory as “proof” that they won’t have to deal with severe testosterone suppression and increased estrogens if they take SARMs. However, this is far from true.
Still, SARMs have surfaced as a popular new class of appearance and performance enhancers. People misperceive them as safer and “cleaner” due to a basic misunderstanding of the available scientific data, which is hyped in various bodybuilding blogs.
Many bodybuilders and athletes swear by Ostarine and claim it offers significant muscle mass and performance gains with few risks.
In reality, the “SARMs selectivity theory” might be completely false. It has never been proven, and SARMs like Ostarine never passed proper clinical trials. SARMs may turn out to be much more dangerous than previously thought.
To create further confusion, some researchers believe Ostarine might be safer than steroids, though they still have no data to back up their claims. Additionally, it has not yet been approved for human use anywhere in the world.
Ostarine is being researched for its ability to improve serious muscle wasting diseases. Interestingly enough, it is one of the few SARMs still in clinical trials while most others proved to be toxic. It may be approved for clinical use if the trials attest to its favorable benefits/risks ratio.